Peter Kelly trained in clinical neurology and stroke in Dublin and in Massachusetts General Hospital in Boston. He is now a busy clinician, Stroke Service co-leader, and Professor of Neurology at Mater University Hospital/University College Dublin. He holds a Bachelors and Doctorate of Medicine, and a Masters in Physiology from UCD, and a Masters degree in Clinical Investigation from Harvard/Massachusetts Institute of Technology Boston.
He has published widely in leading journals, mainly in stroke prevention, but also in acute stroke and recovery. His research focus is on clinical trials and risk prediction in atherosclerosis, TIA and atrial fibrillation using MRI, PET, and blood biomarkers. He is Chief Investigator on the international CONVINCE trial and several other studies, and Lead Investigator for the Stroke Clinical Trials Network Ireland.
From 2010-16, he was co-lead for the Irish National Stroke Programme, which oversaw major improvements in clinical care for stroke in Ireland. He continues to collaborate with North American colleagues, and served for 3 years on the Planning Committee for the AHA/ASA International Stroke Conference.
Currently ESO president, Prof Kelly is a strong believer in the ESO principles of democracy, transparency, fairness and collegiality. He is committed to actively promoting inclusion of women, young physicians, and colleagues from Eastern Europe in ESO leadership structures and activities.
